دورية أكاديمية

Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases

التفاصيل البيبلوغرافية
العنوان: Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases
المؤلفون: Clarke, Paul A, Ortiz-Ruiz, Maria-Jesus, TePoele, Robert, Adeniji-Popoola, Olajumoke, Box, Gary, Court, Will, Czasch, Stephanie, El Bawab, Samer, Esdar, Christina, Ewan, Ken, Gowan, Sharon, De Haven Brandon, Alexis, Hewitt, Phillip, Hobbs, Stephen M, Kaufmann, Wolfgang, Mallinger, Aurélie, Raynaud, Florence, Roe, Toby, Rohdich, Felix, Schiemann, Kai, Simon, Stephanie, Schneider, Richard, Valenti, Melanie, Weigt, Stefan, Blagg, Julian, Blaukat, Andree, Dale, Trevor C, Eccles, Suzanne A, Hecht, Stefan, Urbahns, Klaus, Workman, Paul, Wienke, Dirk
المساهمون: Breast Cancer Now, Cancer Research UK
المصدر: eLife ; volume 5 ; ISSN 2050-084X
بيانات النشر: eLife Sciences Publications, Ltd
سنة النشر: 2016
المجموعة: eLife (E-Journal - via CrossRef)
الوصف: Mediator-associated kinases CDK8/19 are context-dependent drivers or suppressors of tumorigenesis. Their inhibition is predicted to have pleiotropic effects, but it is unclear whether this will impact on the clinical utility of CDK8/19 inhibitors. We discovered two series of potent chemical probes with high selectivity for CDK8/19. Despite pharmacodynamic evidence for robust on-target activity, the compounds exhibited modest, though significant, efficacy against human tumor lines and patient-derived xenografts. Altered gene expression was consistent with CDK8/19 inhibition, including profiles associated with super-enhancers, immune and inflammatory responses and stem cell function. In a mouse model expressing oncogenic beta-catenin, treatment shifted cells within hyperplastic intestinal crypts from a stem cell to a transit amplifying phenotype. In two species, neither probe was tolerated at therapeutically-relevant exposures. The complex nature of the toxicity observed with two structurally-differentiated chemical series is consistent with on-target effects posing significant challenges to the clinical development of CDK8/19 inhibitors.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.7554/elife.20722
الإتاحة: https://doi.org/10.7554/elife.20722Test
https://cdn.elifesciences.org/articles/20722/elife-20722-v3.pdfTest
https://cdn.elifesciences.org/articles/20722/elife-20722-v3.xmlTest
https://elifesciences.org/articles/20722Test
حقوق: http://creativecommons.org/licenses/by/4.0Test/ ; http://creativecommons.org/licenses/by/4.0Test/ ; http://creativecommons.org/licenses/by/4.0Test/
رقم الانضمام: edsbas.63194FE5
قاعدة البيانات: BASE